Showing posts with label Market:. Show all posts
Showing posts with label Market:. Show all posts

Friday, May 8, 2009

Global Intravenous (IV) Iron Drugs Market: Potential Opportunities

Iron deficiency anemia or IDA is among one of the top ten most important public health issues, according to the World Health Organization. With approximately one-third of the current global population facing the problem of iron deficiency, more and more people are likely to suffer from a lack of iron in their diet in the near future due to changes in eating habits and rising life expectancy.

Currently, iron supplements used in the context of IDA account for the majority share of the iron-based medicines but this is likely to change with the growing utility of intravenous iron (IV) drugs. Earlier, the IV iron market was mainly achieved in the hemodialysis (HD) setting, but IV iron is likely to be used more in many other therapeutic areas which are highly under-penetrated.

One of the major attractiveness of IV iron especially in regions outside the United States is its pricing and growing number of CKD population. Generally the pricing of IV irons outside the U.S. is lower and the iron market in countries like China is underdeveloped, but growing rapidly, with tremendous potential.
Venofer from Galenica Limited has emerged as the undisputed leader in the IV iron drugs market overtaking the market share of Watson’s InFed and Ferrlecit. Still the whole IV iron market holds immense business opportunities mainly because of increase in the number of haemodialysis patients and limitation in various iron replacement therapies and scope for innovation.

The report titled “Global Intravenous (IV) Iron Drugs Market: Potential Opportunities” analyzes the IV iron market in the context of opportunities it holds for iron drug manufacturers. The report presents statistics on the growing population of patients who are suffering from critical conditions that calls for the need of iron drugs. Further, it analyzes the factors that could drive the growth of IV drugs market in the future. It also profiles the two major manufacturers of iron drugs – Galenica and Watson Pharma. Further, the future growth of the IV iron drugs market has been analyzed in the report.

For more information kindly visit
http://www.aarkstore.com/reports/Global-Intravenous-IV-Iron-Drugs-Market-Potential-Opportunities-7198.html

Global Seeds Market: Focus on Genetically Modified Segment

Industrialization is changing the dynamics of the global seeds industry. The agriculture land is not going to increase over a period of time; in fact, it is decreasing owing to the growing industrialization world over. The agricultural land is increasingly being used for setting up of industries. This is putting pressure on agricultural sector as the increasing population is driving food demand.

The need of the hour is to produce more crops with the same or the diminishing land. This has in a way sacrificed the variety of crops we used to have once. Companies have introduced hybrid seeds and then introduced biotech traits into them which made them resistant to many diseases and calamities. Moreover, these corporate giants patented these seeds in their names, to make their sales grow and make them more profitable. This is gradually killing the traditional way where farmers would save the seeds for the next season. Rather now they have to buy them every time from these companies. The government is also promoting these biotech or hybrid seeds in order to make up for the increasing food demand.

So, the agricultural sector is changing hands, although slowly, from the farmers to the seed giants. Monsanto, DuPont, Syngenta are the few big players in the seed industry. Another interesting trend in the industry, however contradictory to the cause of introducing these biotech crops, is the use of crops as biofuels, sacrificing the need for food. Governments as well as companies are encouraging farmers to grow crops which can be used for biofuels.

The biggest challenge now is, one, whether these biotech crops are really satisfying the cause and secondly, how to protect the non-biotech or the conventional crops from getting contaminated by the genetically modified crops.

The report is an attempt to analyze the size of the global seeds market, focusing primarily on the biotech seeds industry, along with the forecast of the industry size. The growth drivers and major issues facing the industry are also being touched upon. The major players of the industry are being profiled, highlighting their strategies.

For more information kindly visit
http://www.aarkstore.com/reports/Global-Seeds-Market-Focus-on-Genetically-Modified-Segment-6800.html

Global Seeds Market: Focus on Genetically Modified Segment

Industrialization is changing the dynamics of the global seeds industry. The agriculture land is not going to increase over a period of time; in fact, it is decreasing owing to the growing industrialization world over. The agricultural land is increasingly being used for setting up of industries. This is putting pressure on agricultural sector as the increasing population is driving food demand.

The need of the hour is to produce more crops with the same or the diminishing land. This has in a way sacrificed the variety of crops we used to have once. Companies have introduced hybrid seeds and then introduced biotech traits into them which made them resistant to many diseases and calamities. Moreover, these corporate giants patented these seeds in their names, to make their sales grow and make them more profitable. This is gradually killing the traditional way where farmers would save the seeds for the next season. Rather now they have to buy them every time from these companies. The government is also promoting these biotech or hybrid seeds in order to make up for the increasing food demand.

So, the agricultural sector is changing hands, although slowly, from the farmers to the seed giants. Monsanto, DuPont, Syngenta are the few big players in the seed industry. Another interesting trend in the industry, however contradictory to the cause of introducing these biotech crops, is the use of crops as biofuels, sacrificing the need for food. Governments as well as companies are encouraging farmers to grow crops which can be used for biofuels.

The biggest challenge now is, one, whether these biotech crops are really satisfying the cause and secondly, how to protect the non-biotech or the conventional crops from getting contaminated by the genetically modified crops.

The report is an attempt to analyze the size of the global seeds market, focusing primarily on the biotech seeds industry, along with the forecast of the industry size. The growth drivers and major issues facing the industry are also being touched upon. The major players of the industry are being profiled, highlighting their strategies.

For more information kindly visit
http://www.aarkstore.com/reports/Global-Seeds-Market-Focus-on-Genetically-Modified-Segment-6800.html